Literature DB >> 4209357

The immunology of experimental Chagas' disease. 3. Rejection of allogeneic heart cells in vitro.

C A Santos-Buch, A R Teixeira.   

Abstract

Experiments that consisted of incubation of Trypanosoma cruzi-sensitized lymphocytes derived from chronically infected rabbits and from rabbits repeatedly immunized with a small particle or membrane fraction derived from homogenates of T. cruzi forms, showed destruction of allogeneic, parasitized and nonparasitized heart cells in vitro. Mononuclear cells collected from peripheral blood were incubated for 1 h at 37 degrees C to isolate the lymphocytes. Following incubation, over 99% of the cells in the supernate were lymphocytes, which were utilized in these experiments. At the start of these experiments, 70-80% of the sensitized lymphocytes were unattached, small and round, with sparse filipodia. In the ensuing hours, marked heart cell destruction, similar to that seen in an active lesion when lymphocytes invade heart tissue, were observed. After 18 h incubation, about 65-70% of the lymphocytes were attached, larger, and rough surfaced. Inhibition of monocyte migration tests, each in the presence of the antigens of subcellular fractions of T. cruzi organisms and of allogeneic heart myofibers, indicated the presence of a cross-reacting antigen common to both the parasite and the heart in the small particle or membrane fractions. The particulate antigens of the 30,000 g, 35-min fraction of heart muscle gave rise to inhibition of monocyte migration as did the counterpart fraction derived from T. cruzi organisms. The destruction of nonparasitized target heart cells by T. cruzi-sensitized lymphocytes is an in vitro model of the chronic myocarditis of Chagas' disease, and the recognition of cross-reactive antigens of the host cell by T. cruzi-sensitized lymphocytes is believed to be the pathogenic basis for subsequent tissue injury in the chronic phase of this disease.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4209357      PMCID: PMC2139708          DOI: 10.1084/jem.140.1.38

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Cytotoxicity of human lymphocytes: antagonism between inducing processes.

Authors:  G Lundgren; L Collste; G Möller
Journal:  Nature       Date:  1968-10-19       Impact factor: 49.962

2.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

3.  Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells.

Authors:  G A Granger; S J Shacks; T W Williams; W P Kolb
Journal:  Nature       Date:  1969-03-22       Impact factor: 49.962

4.  Effect of specific antibody to target cells on their specific and non-specific interactions with lymphocytes.

Authors:  I C MacLennan; G Loewi
Journal:  Nature       Date:  1968-09-07       Impact factor: 49.962

5.  Production of complement by spleen cells in vitro and its possible role in an allograft rejection model.

Authors:  H E Taylor; C F Culling
Journal:  Nature       Date:  1968-11-02       Impact factor: 49.962

6.  Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes.

Authors:  J Mauel; H Rudolf; B Chapuis; K T Brunner
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

7.  Cytotoxicity: specificity after in vitro sensitization.

Authors:  S Solliday; F H Bach
Journal:  Science       Date:  1970-12-25       Impact factor: 47.728

8.  Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity.

Authors:  K T Brunner; J Mauel; H Rudolf; B Chapuis
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

9.  Studies on the mechanism of the cytolytic effect of sensitized lymphocytes.

Authors:  W Rosenau; H D Moon
Journal:  J Immunol       Date:  1966-01       Impact factor: 5.422

10.  Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis.

Authors:  J R David
Journal:  J Exp Med       Date:  1965-12-01       Impact factor: 14.307

View more
  41 in total

1.  Immunopathologic and morphologic studies of skeletal muscle in Chagas' disease.

Authors:  R P Laguens; P M Cossio; C Diez; A Segal; C Vasquez; E Kreutzer; E Khoury; R M Arana
Journal:  Am J Pathol       Date:  1975-07       Impact factor: 4.307

2.  In vitro cellular immunity in Chagas' disease.

Authors:  M A Toledo Barros; V Amato Neto; E Mendes; I Mota
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

3.  Cardiac M(2) muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia.

Authors:  J C Goin; E S Borda; S Auger; R Storino; L Sterin-Borda
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

4.  [Immunologic reaction in parasitic invasion (author's transl)].

Authors:  O Zwisler
Journal:  Z Parasitenkd       Date:  1977-06-03

5.  Prevalence of gallstones in 1,229 patients submitted to surgical laparoscopic treatment of GERD and esophageal achalasia: associated cholecystectomy was a safe procedure.

Authors:  Rubens Antonio Aissar Sallum; Eduardo Messias Hirano Padrão; Sergio Szachnowicz; Francisco C B C Seguro; Edno Tales Bianchi; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2015 Apr-Jun

6.  Elaboration by mammalian mesenchymal cells infected with Trypanosoma cruzi of a fibroblast-stimulating factor that may contribute to chagasic cardiomyopathy.

Authors:  D J Wyler; P Libby; S Prakash; R P Prioli; M E Pereira
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

Review 7.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

8.  Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi.

Authors:  L V Rizzo; E Cunha-Neto; A R Teixeira
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

9.  The immunology of experimental Chagas' disease. IV. Production of lesions in rabbits similar to those of chronic Chagas' disease in man.

Authors:  A R Teixeira; M L Teixeira; C A Santos-Buch
Journal:  Am J Pathol       Date:  1975-07       Impact factor: 4.307

Review 10.  Chagas heart disease pathogenesis: one mechanism or many?

Authors:  Kevin M Bonney; David M Engman
Journal:  Curr Mol Med       Date:  2008-09       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.